At the opposite of the interactions spectrum, recurrent or prolonged malaria episodes may activate latently infected resting CD4+ T-cells, inducing latent virus reactivation and potentially reducing the reservoir burden in patients on effective combination antiretroviral therapy (cART) [32]. This evidence concerns the gene CD4 and malaria.